Pfizer COVID-19 booster shot reduces severity of disease, study suggests localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the third dose of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2.
New research into the effectiveness of the Pfizer COVID-19 booster shot suggests getting a third dose significantly reduces the risk of disease-related hospitalization and death.
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world’s largest integrated health record
The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the effectiveness of the Pfizer/BioNTech BNT162B2 vaccine against the Delta variant of SARS-CoV-2 among adolescents.